Shire Human Genetic Therapies, Inc. 4
4 · Translate Bio, Inc. · Filed Jul 2, 2018
Insider Transaction Report
Form 4
Shire Human Genetic Therapies, Inc.
10% Owner
Transactions
- Other
Common Stock
2018-07-02+183,619→ 7,078,945 total
Footnotes (2)
- [F1]These shares were issued upon the closing of the Issuer's initial public offering in satisfaction of contractual obligations, based on the initial public offering price of $13.00 per share, without payment of any additional consideration by Shire Human Genetic Therapies, Inc. at the time of issuance.
- [F2]These shares are owned directly by Shire Human Genetic Therapies, Inc., which is an indirect wholly owned subsidiary of Shire plc. Shire plc is an indirect beneficial owner of the reported securities.